基于糖酵解基因头颈部鳞状细胞癌预后风险模型的构建
Construction of a Prognostic RiskModel for Head and Neck Squamous CellCarcinoma Based on Glycolysis-RelatedGenes
摘要: 目的：基于糖酵解基因构建头颈部鳞状细胞癌的预后风险模型。方法：从TCGA数据库中下载头颈部鳞状 细胞癌的转录组数据和临床信息。从GSEA官网中下载糖酵解相关基因集，并进行基因集富集分析，筛选 出表达有显著差异的糖酵解基因集进行后续分析。使用单因素COX回归分析、多因素COX回归分析、 LASSO回归分析构建头颈部鳞状细胞癌的预后风险模型。将风险评分与年龄、性别、肿瘤分期、分级等 临床特征结合，构建动态列线图并绘制校准曲线。使用cbioportal进行模型基因突变情况分析和模型基 因的差异分析。用Kaplan-Meier法进行高风险组和低风险组总生存期差异分析和数据分层分析。结果： 成功构建出基于16个糖酵解基因的头颈部鳞状细胞癌的预后风险模型，并且可以作为独立预测因子预测 患者的预后。结论：基于16个糖酵解基因构建出的HNSCC的预后风险模型，为HNSCC的诊断、治疗以及 预后提供新的靶点和方向。
Abstract: Objective: To construct a prognostic risk model for head and neck squamous cell carcinoma based on glycolysis-related genes. Methods: The transcriptome data and clinical information of head and neck squamous cell carcinoma were downloaded from TCGA database. Glycolytic gene sets were downloaded from the official website of GSEA, and gene set enrichment analysis was conducted to screen out glycolytic gene sets with significant differences in expression for subsequent analysis. Univariate COX regression analysis, multivariate COX regression analysis and LASSO regression analysis were used to construct the prognostic risk model of head and neck squamous cell carcinoma. The risk score was combined with clinical characteristics such as age, gender, tumor stage and grade to construct a dynamic nomogram and draw a calibration curve. Cbioportal was used to analyze the mutation status of model genes and the difference of model genes. Kaplan-Meier method was used to analyze the difference of overall survival between the high-risk group and the low-risk group and to analyze the data stratification. Results: The prognostic risk model of head and neck squamous cell carcinoma based on 16 glycolysis-related genes was successfully constructed and could be used as an independent predictor to predict the prognosis of patients. Conclusion: The prognostic risk model of HNSCC based on 16 glycolysis-related genes provides a new target and direction for the diagnosis, treatment and prognosis of HNSCC.
文章引用：孔静文, 汪若璜. 基于糖酵解基因头颈部鳞状细胞癌预后风险模型的构建[J]. 临床医学进展, 2022, 12(11): 9911-9923. https://doi.org/10.12677/ACM.2022.12111430

参考文献

[1] Mcdermott, J. and Bowles, D. (2019) Epidemiology of Head and Neck Squamous Cell Carcinomas: Impact on Staging and Prevention Strategies. Current Treatment Options in Oncology, 20, Article No. 43. [Google Scholar] [CrossRef] [PubMed]
[2] Li, C., Wu, Z. and Yuan, K. (2020) Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Disease Markers, 2020, Article ID: 8899337. [Google Scholar] [CrossRef] [PubMed]
[3] Yasui, K., Kondou, R., Miyata, H., et al. (2022) Immunological and Genetic Characterization of Patients with Head and Neck Cancer Who Developed Recurrence. Anticancer Research, 42, 4417-4428. [Google Scholar] [CrossRef] [PubMed]
[4] Hu, C., Xuan, Y., Zhang, X., et al. (2022) Immune Cell Metabolism and Metabolic Reprogramming. Molecular Biology Reports, 49, 9783-9795. [Google Scholar] [CrossRef] [PubMed]
[5] Li, X., Yang, Y., Zhang, B., et al. (2022) Lactate Metabolism in Human Health and Disease. Signal Transduction and Targeted Therapy, 7, Article No. 305. [Google Scholar] [CrossRef] [PubMed]
[6] Sengun, S., Korkmaz, H., Ciris, M., et al. (2022) Diagnostic and Prognostic Value of Stanniocalcin 1 Expression in Papillary Thyroid Cancer. Endocrine, 78, 95-103. [Google Scholar] [CrossRef] [PubMed]
[7] Li, H., Zhou, X., Zhang, H., et al. (2022) Combined Efficacy of CXCL5, STC2, and CHI3L1 in the Diagnosis of Colorectal Cancer. Journal of Oncology, 2022, Article ID: 7271514. [Google Scholar] [CrossRef] [PubMed]
[8] Li, D., Cheng, X., Zheng, W., et al. (2020) Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma. Cancer Manage-ment and Research, 12, 4923-4935. [Google Scholar] [CrossRef] 
[9] Liang, C., Wang, Y., Wei, Y., et al. (2020) Identification of Novel EXT Mutations in Patients with Hereditary Multiple Exostoses Using Whole-Exome Sequencing. Orthopaedic Surgery, 12, 990-996. [Google Scholar] [CrossRef] [PubMed]
[10] Li, T., Song, L., Zhang, Y., et al. (2020) Molecular Mechanism of c-Myc and PRPS1/2 against Thiopurine Resistance in Burkitt’s Lymphoma. Journal of Cellular and Molecular Medi-cine, 24, 6704-6715. [Google Scholar] [CrossRef] [PubMed]
[11] Li, Y., Tian, H., Luo, H., et al. (2020) Prognostic Significance and Relat-ed Mechanisms of Hexokinase 1 in Ovarian Cancer. OncoTargets and Therapy, 13, 11583-11594. [Google Scholar] [CrossRef] 
[12] Liu, Z., Wang, Y., Yang, F., et al. (2021) GMPPB-Congenital Disor-ders of Glycosylation Associate with Decreased Enzymatic Activity of GMPPB. Molecular Biomedicine, 2, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[13] Yu, L., Guo, Q., Luo, Z., et al. (2022) TXN Inhibitor Impedes Radioresistance of Colorectal Cancer Cells with Decreased ALDH1L2 Expression via TXN/NF-κB Signaling Pathway. British Journal of Cancer, 127, 637-648. [Google Scholar] [CrossRef] [PubMed]
[14] Tang, Y., Yin, Y., Xie, M., et al. (2021) Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer. Frontiers in Molecular Biosci-ences, 8, Article ID: 733271. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, M., Chen, B., Kong, L., et al. (2022) HMMR Promotes Peritoneal Implantation of Gastric Cancer by Increasing Cell-Cell Interactions. Discover Oncology, 13, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
[16] Li, W., Liu, B., Dong, S., et al. (2022) Bioinformatics and Ex-perimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer. Frontiers in Oncology, 12, Article ID: 856712. [Google Scholar] [CrossRef] [PubMed]
[17] Fu, D., He, C., Wei, J., et al. (2018) PGK1 Is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer. Cellular Physiology & Biochemistry, 51, 2434-2444. [Google Scholar] [CrossRef] [PubMed]
[18] Liang, C., Shi, S., Qin, Y., et al. (2020) Localisation of PGK1 Determines Metabolic Phenotype to Balance Metastasis and Pro-liferation in Patients with SMAD4-Negative Pancreatic Cancer. Gut, 69, 888-900. [Google Scholar] [CrossRef] [PubMed]
[19] Zhou, J., Tang, J., Sun, W., et al. (2019) PGK1 Facilities Cisplatin Chemoresistance by Triggering HSP90/ERK Pathway Mediated DNA Repair and Methylation in Endometrial Endome-trioid Adenocarcinoma. Molecular Medicine, 25, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
[20] Ge, J., Li, J., Na, S., et al. (2019) miR-548c-5p Inhibits Colorectal Cancer Cell Proliferation by Targeting PGK1. Journal of Cellular Physiology, 234, 18872-18878. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, Q., Li, J., Zhang, W., et al. (2021) Glycogen Accumulation and Phase Separation Drives Liver Tumor Initiation. Cell, 184, 5559-5576.e19. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, X., Zhang, H., Sapio, R., et al. (2021) SOD1 Regulates Ri-bosome Biogenesis in KRAS Mutant Non-Small Cell Lung Cancer. Nature Communications, 12, Article No. 2259. [Google Scholar] [CrossRef] [PubMed]
[23] Sen, S., Kawahara, B., Mahata, S., et al. (2016) Cystathionine: A Novel Oncometabolite in Human Breast Cancer. Archives of Biochemistry and Biophysics, 604, 95-102. [Google Scholar] [CrossRef] [PubMed]
[24] Gong, X., Wang, A. and Song, W. (2022) Clinicopathological Sig-nificances of PLOD2, Epithelial-Mesenchymal Transition Markers, and Cancer Stem Cells in Patients with Esophageal Squamous Cell Carcinoma. Medicine (Baltimore), 101, e30112. [Google Scholar] [CrossRef] 
[25] Sun, X., Xue, H., Xiong, Y., et al. (2019) GALE Promotes the Proliferation and Migration of Glioblastoma Cells and Is Regulated by miR-let-7i-5p. Cancer Management and Re-search, 11, 10539-10554. [Google Scholar] [CrossRef] 

为你推荐